Treatment Action Group (TAG) released the latest installment of its 2026 Pipeline Report series on TB Vaccines, written by TB ...
Researchers discovered a previously unknown pathway that helps HIV stay hidden in the body, even when patients are taking ...
In previously untreated adults with HIV-1, initiating therapy with either DOR/ISL or BIC/FTC/TAF results in comparable enhancements in overall health status.
Dr Fiona Creswell, a physician and clinical researcher at the MRC/UVRI & LSHTM Uganda Research Unit explores what the IMPALA trial tells about the potential of long-acting HIV treatment in Africa, and ...
Investigational asuptegravir cut HIV-1 RNA by up to 2.36 log10 copies/mL in 10 days, and adding fostemsavir boosted CD4 gains in immunologic nonresponders.
Older HIV patients with metabolic comorbidities who transition to a single-tablet BIC/LEN experience low rates of severe adverse events and treatment discontinuations.
Recombinant zoster vaccination may reduce incident heart failure risk in adults with HIV, providing a protective effect against risks heightened by herpes zoster.
Achieving the UNAIDS global HIV targets for 2030 could reduce annual new HIV infections by 77%, according to a modeling study ...
Infectious Disease Advisor | Long-term ART does not reduce anogenital cancer risk in people with HIV
Despite immune function restoration, individuals with HIV who receive prolonged ART continue to face a substantially higher ...
The research, published in the Journal of NeuroVirology, found that among people living with HIV (PLWH), slower walking speed ...
More than a decade after WHO recommended HIV self-testing, a new analysis argues the technology’s promise has been squandered ...
Researchers used a model to simulate the impact of the new HBV vaccination recommendations in the US on HBV infections and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results